News Archive
Remote Access
O365 Access DIAM VDI DIAM Remote Access TAC Remote Access (DMMI, DMAR, DMCN) DMTN VDI DMAT VDI DMTN Remote Access DMAT Remote Access DPAM Remote Access DSCN Remote Access

Quick Links

DENSO North America Website DENSO Presentation Library Oracle Fusion Oracle Fusion Help DENSO Benefits Healthy Horizons Empower Retirement DMTN Associate Resource Center
News Archive
Remote Access
O365 Access DIAM VDI DIAM Remote Access TAC Remote Access (DMMI, DMAR, DMCN) DMTN VDI DMAT VDI DMTN Remote Access DMAT Remote Access DPAM Remote Access DSCN Remote Access

Coronavirus

DENSO continues to monitor the risks of COVID-19 to our associates and operations


Key Documents & Links

  • US Face Mask Policy
  • COVID-19 Record System
  • NA Risk Minimization Toolkit
  • Travel & Visitor Guidelines
  • Business Ethics & Compliance Resources
  • CDC website

Who to Contact

Please contact us if you have any questions or concerns.

North America
COVID-19 Task Force
 
covid@na.denso.com

BCBSM Nurse Helpline
(for BCBSM members only)
tel: 1-800-775-2583  

Back

Share this:

April 5, 2021

DIAM COVID-19 Weekly Case Count (March 26-April 1, 2021)

DENSO International America, Inc.
Weekly COVID-19 Case Update

This week, we learned that two (2) DIAM associates were diagnosed with COVID-19.

  • One associate was last on site at DIAM Southfield on December 18, and received a positive diagnosis on March 27.
  • One associate was last on site at DIAM Southfield in January 19, and received a positive diagnosis on March 29.

Because the associates have not been on-site recently, there is no need for additional cleaning and sanitizing. Please respect confidentiality, even if you believe you know who these individuals are.

3 Ways to Access to DIAM Screening Survey:

All associates are required to complete the COVID-19 Daily Screening Survey prior to every DIAM campus visit.

1. Survey Link: www.densomedia-na.com/coronavirus/survey/  (Note: if you are using the Outlook mobile app, you will need to download the Edge browser from the Company Portal in order to view this link). If you go to campus regularly – bookmark this link!

2. DENSO Mobile: Go to densomobile.com and create your account or login. Once you’re on DENSO Mobile, click on the scrolling graphic at the top of the app labeled “COVID-19 Screening Survey”.

3. DENSO Online: Go to densoonline.com and click on the “Coronavirus” section (password: denso2020). Find the survey under “Key Documents & Links”.

 

If you have COVID-19 Symptoms or Diagnosis:

  • Do not come to any DIAM campus
  • Inform your manager or chain of command
  • You or your manager needs to send an email to covid@na.denso.com with the following details: date symptoms started, date of last day onsite, date of COVID-19 test results
  • Someone will follow up with you to gather additional information

 Some symptoms may include: fever, cough, fatigue, shortness of breath, chills, persistent headache, loss of smell or taste. For a complete list of COVID-19 symptoms, visit the CDC website.

DENSO North America
Weekly COVID-19 Case Update

This week at DENSO affiliates in North America, 42 positive COVID-19 diagnoses were reported. Throughout Canada, Mexico and the United States (U.S.), DENSO has reported a total of 2,938 total positive diagnoses.

Following local investigations into cases at DENSO facilities this week, most were classified as community spread (household, gatherings, travel, etc.). Three cases in Michigan were classified as workplace spread, so additional countermeasures are under discussion.

Country This Week’s Cases Total Positive Diagnosis Number of Deaths Exposed in Community Exposed at DENSO Unable to Determine Under Investigation
US 38 1651 4 1626 17 8 0
MX 2 1277 4 1202 48 27 0
CN 2 10 0 10 0 0 0
NA TOTALS 42 2938 8 2838 65 35 0

Exposed in Community – transmission attributed to community or home

Exposed at DENSO – transmission attributed to DENSO site contact

Unable to Determine – cannot confidently determine the source of exposure after thorough investigation (may have been exposed outside or inside of work)

Under Investigation – investigation is on-going both internally as well as with county health departments

COVID-19 Vaccine: How long does it take for the COVID vaccination to be effective?

It typically takes two weeks after vaccination for the body to build protection (immunity) against the virus that causes COVID-19. That means it is possible a person could still get COVID-19 before or just after vaccination and then get sick because the vaccine did not have enough time to provide protection.  People are considered fully protected two weeks after their second dose of the Pfizer-BioNTech or Moderna COVID-19 vaccine, or two weeks after the single-dose Johnson & Johnson’s Janssen COVID-19 vaccine.

You should keep using all the tools available to protect yourself and others until you are fully vaccinated. After you are fully vaccinated, you may be able to start doing some things you had stopped doing because of the pandemic. Learn more about what you can do when you have been fully vaccinated.

Let’s Learn Together:  Do DENSO safety guidelines change when local/state government restrictions do?

DENSO’s Risk Minimization Toolkit, and policies for masking, cleaning and social distancing will continue to follow CDC guidelines. As COVID-19 variants increase the spread of coronavirus, we must remain committed to protecting ourselves and each other. As vaccination rates increase, some state and local government orders may change policies in your community, but DENSO policies have not changed. COVID-19 safety policies, including face masks, are required at all DENSO North America sites, and we recommend that you follow all best practices for COVID safety in the community as well, including during business travel.

 

Published by DENSO INTERNATIONAL AMERICA, INC. for associates and friends of DENSO companies, joint ventures and affiliates in North America.

Follow Us

©DENSO INTERNATIONAL AMERICA, INC. 2023 All rights reserved. Ownership and Use

✖